| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Ocuphire Pharma to Present at the Aegis Virtual Conference | 2 | GlobeNewswire (USA) | ||
| 17.04. | Ocuphire Pharma, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
| 11.04. | Ocuphire Pharma: First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery | 108 | GlobeNewswire (Europe) | LYNX-2 Follows SPA Agreement with FDA Development of PS is Funded by Ocuphire's Partner Viatris FARMINGTON HILLS, Mich., April 11, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP)... ► Artikel lesen | |
| 01.04. | Ocuphire Pharma: Ocuphire Announces the U.S. Commercial Launch of RYZUMVl (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris | 377 | GlobeNewswire (Europe) | FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment... ► Artikel lesen | |
| 25.03. | Ocuphire Pharma CFO acquires $21,000 worth of company stock | 5 | Investing.com | ||
| 25.03. | Ocuphire Pharma COO acquires $4.1k in company stock | 5 | Investing.com | ||
| 20.03. | Ocuphire Pharma CEO buys $49,050 in company stock | 6 | Investing.com | ||
| 08.03. | Ocuphire Pharma, Inc. - 10-K, Annual Report | 6 | SEC Filings | ||
| 08.03. | Ocuphire Pharma GAAP EPS of -$0.21 misses by $0.21, revenue of $1.69M misses by $4.27M | 5 | Seeking Alpha | ||
| 08.03. | Ocuphire Pharma, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 08.03. | Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update | 184 | GlobeNewswire (Europe) | FARMINGTON HILLS, Mich., March 08, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule... ► Artikel lesen | |
| 23.02. | Ocuphire Pharma to Present in the BIO CEO & Investor Conference | 5 | GlobeNewswire (USA) | ||
| 16.02. | Ocuphire Pharma, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 15.02. | Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 193 | GlobeNewswire (Europe) | FARMINGTON HILLS, Mich., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule... ► Artikel lesen | |
| 14.02. | Ocuphire Pharma appointed Nirav Jhaveri as CFO | 3 | Seeking Alpha | ||
| 14.02. | Ocuphire Pharma Strengthens Leadership Team with Key Appointments | 230 | GlobeNewswire (Europe) | Ash Jayagopal, Ph.D., M.B.A. Appointed Chief Scientific and Development Officer Nirav Jhaveri, C.F.A, M.B.A. Appointed as Chief Financial Officer FARMINGTON HILLS, Mich., Feb. 14, 2024 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 05.02. | Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 Conference | 5 | GlobeNewswire (USA) | ||
| 24.01. | Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 6 | GlobeNewswire (USA) | ||
| 11.01. | Ocuphire Pharma, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 7 | SEC Filings | ||
| 11.01. | Here's Why You Should Invest in Ocuphire Pharma (OCUP) Now | 11 | Zacks |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 551 |
| BAYER | 356 |
| BYD | 303 |
| NEL | 289 |
| NVIDIA | 267 |
| PLUG POWER | 249 |
| DEUTSCHE BANK | 245 |
| TESLA | 245 |
| TUI | 244 |
| SUPER MICRO COMPUTER | 229 |
| APPLE | 222 |
| RHEINMETALL | 211 |
| RWE | 202 |
| DEUTSCHE LUFTHANSA | 188 |
| MERCEDES-BENZ | 188 |
| AMAZON | 180 |
| BERKSHIRE HATHAWAY | 173 |
| RENK GROUP | 151 |
| VOLKSWAGEN | 145 |
| BIONTECH | 144 |
| COMMERZBANK | 144 |
| ALLIANZ | 141 |
| AIXTRON SE | 139 |
| BASF | 136 |
| PAYPAL | 135 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
